← Evidence map

TrialCancer medicine2014

Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer.

Dana B Cardin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24574334